Heart Failure Impairs Muscle Blood Flow and Endurance Exercise Tolerance in COPD
- 20 January 2016
- journal article
- research article
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 13 (4) , 407-415
Abstract
Heart failure, a prevalent and disabling co-morbidity of COPD, may impair cardiac output and muscle blood flow thereby contributing to exercise intolerance. To investigate the role of impaired central and peripheral hemodynamics in limiting exercise tolerance in COPD-heart failure overlap, cycle ergometer exercise tests at 20% and 80% peak work rate were performed by overlap (FEV1 = 56.9 ± 15.9% predicted, ejection fraction = 32.5 ± 6.9%; N = 16), FEV1-matched COPD (N = 16), ejection fraction-matched heart failure patients (N = 15) and controls (N = 12). Differences (Δ) in cardiac output (impedance cardiography) and vastus lateralis blood flow (indocyanine green) and deoxygenation (near-infrared spectroscopy) between work rates were expressed relative to concurrent changes in muscle metabolic demands (ΔO2 uptake). Overlap patients had approximately 30% lower endurance exercise tolerance than COPD and heart failure (p < 0.05). ΔBlood flow was closely proportional to Δcardiac output in all groups (r = 0.89–0.98; p < 0.01). Overlap showed the largest impairments in Δcardiac output/ΔO2 uptake and Δblood flow/ΔO2 uptake (p < 0.05). Systemic arterial oxygenation, however, was preserved in overlap compared to COPD. Blunted limb perfusion was related to greater muscle deoxygenation and lactate concentration in overlap (r = 0.78 and r = 0.73, respectively; p < 0.05). ΔBlood flow/ΔO2 uptake was related to time to exercise intolerance only in overlap and heart failure (p < 0.01). In conclusion, COPD and heart failure add to decrease exercising cardiac output and skeletal muscle perfusion to a greater extent than that expected by heart failure alone. Treatment strategies that increase muscle O2 delivery and/or decrease O2 demand may be particularly helpful to improve exercise tolerance in COPD patients presenting heart failure as co-morbidity.Keywords
This publication has 38 references indexed in Scilit:
- Epidemiology and clinical impact of major comorbidities in patients with COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2014
- Comorbidity of Heart Failure and Chronic Obstructive Pulmonary Disease: More than CoincidenceCurrent Heart Failure Reports, 2014
- Comorbidities and Systemic Effects of Chronic Obstructive Pulmonary DiseaseClinics in Chest Medicine, 2014
- Chronic Obstructive Pulmonary DiseaseClinics in Chest Medicine, 2014
- Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter?European Respiratory Review, 2014
- The physiological basis of rehabilitation in chronic heart and lung diseaseJournal of Applied Physiology, 2013
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Respiratory muscle unloading improves leg muscle oxygenation during exercise in patients with COPDThorax, 2008
- Kinetics of muscle deoxygenation are accelerated at the onset of heavy-intensity exercise in patients with COPD: relationship to central cardiovascular dynamicsJournal of Applied Physiology, 2008
- Heart Failure and cHronic Obstructive Pulmonary Disease: An Ignored Combination?European Journal of Heart Failure, 2006